Plus Therapeutics (PSTV) News Today $1.20 +0.01 (+0.84%) (As of 02:50 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Plus Therapeutics to Present Multi-Institutional Experience Using the CNSide™ Cerebrospinal Fluid Assay in Patients with Leptomeningeal MetastasesNovember 21 at 7:30 AM | globenewswire.comWhat is HC Wainwright's Forecast for PSTV FY2028 Earnings?November 19 at 4:25 AM | americanbankingnews.comPlus Therapeutics, Inc. (NASDAQ:PSTV) Q3 2024 Earnings Call TranscriptNovember 18 at 4:24 PM | msn.comPositive Outlook for Plus Therapeutics: Strong Financial Support and Clinical Advancements Justify Buy RatingNovember 17, 2024 | markets.businessinsider.comPlus Therapeutics, Inc. (PSTV) Q3 2024 Earnings Call TranscriptNovember 16, 2024 | seekingalpha.comPlus Therapeutics Inc.: Plus Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business HighlightsNovember 16, 2024 | finanznachrichten.dePlus Therapeutics: Promising Growth and Stability Backed by Financial Strength and Clinical InnovationsNovember 15, 2024 | markets.businessinsider.comPlus Therapeutics Inc (PSTV) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges ...November 15, 2024 | finance.yahoo.comPlus Therapeutics Advances Radiotherapeutics in Q3 2024November 15, 2024 | markets.businessinsider.comPlus Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business HighlightsNovember 15, 2024 | markets.businessinsider.comPlus Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business HighlightsNovember 14, 2024 | globenewswire.comA Peek at Plus Therapeutics's Future EarningsNovember 13, 2024 | benzinga.comPlus Therapeutics (PSTV) Scheduled to Post Quarterly Earnings on ThursdayNovember 13, 2024 | americanbankingnews.comPlus Therapeutics, SpectronRx announce manufacturing partnershipNovember 6, 2024 | markets.businessinsider.comPlus Therapeutics and SpectronRx Announce Radiotherapeutic Manufacturing PartnershipNovember 6, 2024 | globenewswire.comPlus Therapeutics to Announce Third Quarter Financial Results and Host Conference Call on November 14, 2024November 5, 2024 | globenewswire.comPlus Therapeutics Showcases Leptomeningeal Metastases Programs at the 2024 SNO Annual Meeting in Houston, TexasOctober 29, 2024 | globenewswire.comPlus Therapeutics reports progress in brain cancer trialOctober 3, 2024 | uk.investing.comPlus Therapeutics Reports ReSPECT-GBM Clinical Trial Update at the 2024 Congress of Neurological Surgeons Annual MeetingOctober 1, 2024 | globenewswire.comDow Tumbles Over 200 Points; Carnival Posts Upbeat EarningsSeptember 30, 2024 | benzinga.comPlus Therapeutics (NASDAQ:PSTV) Stock, Short Interest ReportSeptember 29, 2024 | benzinga.comPlus Therapeutics Showcases New Interim ReSPECT-GBM Phase 2 Trial Data at the 2024 Congress of Neurological Surgeons Annual MeetingSeptember 18, 2024 | globenewswire.comPlus Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceSeptember 4, 2024 | globenewswire.comBuy Rating Affirmed for Plus Therapeutics Amid Strong Clinical Results and Positive Financial OutlookAugust 20, 2024 | markets.businessinsider.comPlus Therapeutics Second Quarter 2024 Earnings: Beats ExpectationsAugust 17, 2024 | finance.yahoo.comBuy Rating Affirmed for Plus Therapeutics Amidst Promising Clinical Trial ResultsAugust 15, 2024 | markets.businessinsider.comQ2 2024 Plus Therapeutics Inc Earnings CallAugust 15, 2024 | finance.yahoo.comPlus Therapeutics, Inc. (PSTV) Q2 2024 Earnings Call TranscriptAugust 15, 2024 | seekingalpha.comPlus Therapeutics reports progress in CNS cancer trialAugust 14, 2024 | uk.investing.comPlus Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business HighlightsAugust 14, 2024 | globenewswire.comPlus Therapeutics earnings: here's what Wall Street expectsAugust 14, 2024 | markets.businessinsider.comPlus Therapeutics Presents Positive Clinical Trial Results at the 2024 SNO/ASCO CNS Metastases ConferenceAugust 14, 2024 | markets.businessinsider.comPlus Therapeutics Presents Positive Clinical Trial Results at the 2024 SNO/ASCO CNS Metastases ConferenceAugust 13, 2024 | globenewswire.comPlus Therapeutics Presents Positive Interim ReSPECT-LM Phase 1 Data for Leptomeningeal Metastases at 2024 SNO/ASCO CNS Metastases ConferenceAugust 12, 2024 | globenewswire.comPlus Therapeutics to Announce Second Quarter Financial Results and Host Conference Call on August 14, 2024August 8, 2024 | globenewswire.comPlus Therapeutics Showcases Leptomeningeal Metastases Programs at 2024 SNO/ASCO ConferenceJuly 25, 2024 | markets.businessinsider.comPlus Therapeutics Showcases Leptomeningeal Metastases Programs at 2024 SNO/ASCO ConferenceJuly 25, 2024 | globenewswire.comPlus Therapeutics to Present at the Gordon Research Conference Radionuclide Theranostics for the Management of CancerJuly 2, 2024 | globenewswire.comPlus Therapeutics Expands Management Team and Reports $3.3M Advance Payment from CPRITJune 7, 2024 | globenewswire.comPlus Therapeutics Inc.: Plus Therapeutics Announces New Employment Inducement GrantsMay 18, 2024 | finanznachrichten.dePlus Therapeutics Announces New Employment Inducement GrantsMay 17, 2024 | globenewswire.comPlus Therapeutics, Inc. (NASDAQ:PSTV) Q1 2024 Earnings Call TranscriptMay 16, 2024 | msn.comPlus Therapeutics Inc (PSTV) Q1 2024 Earnings Call Transcript Highlights: Strategic Progress ...May 16, 2024 | finance.yahoo.comPlus: Q1 Earnings SnapshotMay 15, 2024 | sfgate.comPlus Therapeutics Inc. Q1 Loss Decreases, Beats EstimatesMay 15, 2024 | markets.businessinsider.comPlus Therapeutics Reports First Quarter 2024 Financial Results and Recent Business HighlightsMay 15, 2024 | globenewswire.comPlus Therapeutics to Announce First Quarter Financial Results and Host Conference Call on May 15, 2024May 13, 2024 | globenewswire.comPlus Therapeutics CEO buys $25,000 in company stockMay 12, 2024 | uk.investing.comAndrew John Hugh Macintyr Sims Acquires 4,902 Shares of Plus Therapeutics, Inc. (NASDAQ:PSTV) StockMay 11, 2024 | insidertrades.comAnalysts Offer Insights on Healthcare Companies: Charles River Labs (CRL), Plus Therapeutics (PSTV) and Argenx Se (ARGX)May 10, 2024 | markets.businessinsider.com Get Plus Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PSTV and its competitors with MarketBeat's FREE daily newsletter. Email Address Tesla Execs are Freaking Out (Ad)It’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss. Click here to get the details. PSTV Media Mentions By Week PSTV Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PSTV News Sentiment▼0.580.47▲Average Medical News Sentiment PSTV News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PSTV Articles This Week▼151▲PSTV Articles Average Week Get Plus Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PSTV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Interpace Biosciences News Today Neuronetics News Today Femasys News Today NEXGEL News Today NeurAxis News Today Spectral AI News Today Meihua International Medical Technologies News Today ReWalk Robotics News Today Inspira Technologies Oxy B.H.N. News Today PolyPid News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PSTV) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Plus Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Plus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.